Author： Leaman Douglas W
Publisher： Informa Healthcare
ISSN： 1746-0441
Source： Expert Opinion on Drug Discovery, Vol.3, Iss.9, 2008-09, pp. : 997-1009
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Antisense oligonucleotide therapeutics
By Bennett C.F.
Expert Opinion on Investigational Drugs, Vol. 8, Iss. 3, 1999-03 ,pp. :
Access to resources
Recommend
Antisense Anticancer Oligonucleotide Therapeutics
Current Cancer Drug Targets, Vol. 1, Iss. 3, 2001-01 ,pp. :
Antisense and / or Immunostimulatory Oligonucleotide Therapeutics
Current Cancer Drug Targets, Vol. 1, Iss. 3, 2001-11 ,pp. :
Current progress on aptamer-targeted oligonucleotide therapeutics
By Dassie Justin P Giangrande Paloma H
Therapeutic Delivery, Vol. 4, Iss. 12, 2013-12 ,pp. :